[Metabolic factors associated with urolithiasis. Part II (author's transl)].
D000493:Allopurinol / Q000627:therapeutic use; D001647:Bile Acids and Salts / Q000378:metabolism; D002118:Calcium / Q000097:blood; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006961:Hyperparathyroidism / Q000150:complications; D007668:Kidney / Q000378:metabolism; D007926:Lesch-Nyhan Syndrome / Q000378:metabolism; D011687:Purines / Q000378:metabolism; D014527:Uric Acid / Q000652:urine; D014545:Urinary Calculi / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism* / Q000517:prevention & control
D001647:Bile Acids and Salts; D004232:Diuretics; D011687:Purines; D014527:Uric Acid; D000493:Allopurinol; D002118:Calcium
O metabolicznych czynnikach powstawania kamicy moczowej Cz. II